The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores

International Journal of Artificial Organs

Volumn 36, Issue 5, 2013, Pages 314-319

  Afsar, Baris ^a  

^a Konya Numune State Hospital   (Turkey)

Author keywords

Depression; Erythropoietin resistance; Hemodialysis

Indexed keywords

CORRELATION METHODS; HEMODIALYZERS; HEMOGLOBIN; IRON; NUTRITION; PATHOLOGY; PATIENT TREATMENT; REGRESSION ANALYSIS;

'CURRENT; BECK DEPRESSION INVENTORIES; BIOCHEMICAL ANALYSIS; DEPRESSION; DEPRESSIVE SYMPTOM; ERYTHROPOIESIS-STIMULATING AGENTS; ERYTHROPOIETIN RESISTANCE; HAEMODIALYSIS; HEMODIALYSIS PATIENT; MEDICAL HISTORY;

DIALYSIS;

ALBUMIN; C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; PARATHYROID HORMONE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CHEMICAL ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; FEMALE; GENDER; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM;

EID: 84878139212     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000184     Document Type: Article

References (25)

1. Locatelli F, Andrulli S, Memoli B, et al. Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. Nephrol Dial Transplant. 2006;21(4): 991-998.
2. Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: review of causes and management. Blood Purif. 2010;29(1):1-12.
3. Bárány P, Divino Filho JC, Bergström J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis. 1997;29(4): 565-568.
4. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999;33(1):63-72.
5. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003;42(4):761-773.
6. Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223-1229.
7. Montinaro V, Iaffaldano GP, Granata S, et al. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. Clin Nephrol. 2010;73(1):36-43.
8. Ibrahim S, El Salamony O. Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. Am J Nephrol. 2008;28(5):784-791.
9. Kalender B, Ozdemir AC, Koroglu G. Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract. 2006;102(3-4):c115-c121.
10. López-Gómez JM, Portolés JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008;74(S111):S75-S81.
11. López-Gómez JM, Pérez-Flores I, Jofré R, et al. Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol. 2004;15(9):2494-2501.
12. Section IV. Dialysis fluid purity. Nephrol Dial Transplant. 2002;17(Suppl 7):45-62.
13. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
14. Priyadarshi A, Shapiro JI. Erythropoietin resistance in the treatment of the anemia of chronic renal failure. Semin Dial. 2006;19(4):273-278.
15. Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol. 2003;14(7):1776-1784.
16. Del Vecchio L, Pozzoni P, Andrulli S, Locatelli F. Inflammation and resistance to treatment with recombinant human erythropoietin. J Ren Nutr. 2005;15(1):137-141.
17. Shinzato T, Abe K, Furusu A, et al. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia. Med Sci Monit. 2008;14(9):CR431-CR437.
18. Costa E, Lima M, Alves JM, et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol. 2008;28(3):268-275.
19. Preljevic VT, Østhus TB, Sandvik L, et al. Psychiatric disorders, body mass index and C-reactive protein in dialysis patients. Gen Hosp Psychiatry. 2011;33(5):454-461.
20. Simic Ogrizovic S, Jovanovic D, Dopsaj V, et al. Could depression be a new branch of MIA syndrome? Clin Nephrol. 2009;71(2):164-172.
21. Di Iorio B, Cirillo M, Bellizzi V, Stellato D, De Santo NG; Campania Dialysis Registry Research Group. Prevalence and correlates of anemia and uncontrolled anemia in chronic hemodialysis patients-the Campania Dialysis Registry. Int J Artif Organs. 2007;30(4):325-333.
22. Lin CL, Hung CC, Yang CT, Huang CC. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients. Ren Fail. 2004;26(3):289-295.
23. Tangdhanakanond K, Raja R. Effect of statins on erythropoietin responsiveness in type 2-diabetic versus nondiabetic hemodialysis patients. Clin Nephrol. 2010;73(1): 1-6.
24. Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K, Soma M. Relationship between erythropoietin responsiveness, insulin resistance, and malnutrition-inflammationatherosclerosis (MIA) syndrome in hemodialysis patients with diabetes. Int J Artif Organs. 2011;34(1):16-25.
25. Ifudu O, Uribarri J, Rajwani I, et al. Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis. 2001;38(3):518-522.